BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 29143611)

  • 1. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
    Parry JV; Easterbrook P; Sands AR
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of rapid diagnostic tests for detection of Hepatitis B and C markers in HIV infected patients.
    Barbosa JR; Colares JKB; Flores GL; Cortes VF; Miguel JC; Portilho MM; Marques VA; Potsch DV; Brandão-Mello CE; Amendola-Pires M; Pilotto JH; Lima DM; Lampe E; Villar LM
    J Virol Methods; 2017 Oct; 248():244-249. PubMed ID: 28782578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
    Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
    Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of sequential serological testing strategy for detection of Hepatitis B surface antigen (HBsAg) for diagnosing HBV infection.
    Tiwari AK; Pabbi S; Aggarwal G; Arora D; Bhardwaj G; Setya D; Sharma J
    J Virol Methods; 2019 Dec; 274():113726. PubMed ID: 31479692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis.
    Amini A; Varsaneux O; Kelly H; Tang W; Chen W; Boeras DI; Falconer J; Tucker JD; Chou R; Ishizaki A; Easterbrook P; Peeling RW
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):698. PubMed ID: 29143619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the analytical performance of six rapid diagnostic tests for the detection of viral hepatitis B and C in Lubumbashi, Democratic Republic of Congo.
    Kabamba AT; Mwamba CM; Dessilly G; Dufrasne F; Kabamba BM; Longanga AO
    J Virol Methods; 2020 Nov; 285():113961. PubMed ID: 32860797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
    Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
    Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.
    Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S
    Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses.
    Lange B; Cohn J; Roberts T; Camp J; Chauffour J; Gummadi N; Ishizaki A; Nagarathnam A; Tuaillon E; van de Perre P; Pichler C; Easterbrook P; Denkinger CM
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):700. PubMed ID: 29143672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers.
    Miedouge M; Legrand-Abravanel F; Lalanne C; Saune K; Izopet J
    J Clin Virol; 2009 Feb; 44(2):134-7. PubMed ID: 19110466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating HBsAg rapid test performance for different biological samples from low and high infection rate settings & populations.
    Cruz HM; Scalioni Lde P; de Paula VS; da Silva EF; do Ó KM; Milagres FA; Cruz MS; Bastos FI; Pollo-Flores P; Leal E; Motta-Castro AR; Pilotto JH; Lewis-Ximenez LL; Lampe E; Villar LM
    BMC Infect Dis; 2015 Nov; 15():548. PubMed ID: 26619906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus.
    Ismail N; Fish GE; Smith MB
    J Clin Microbiol; 2004 Feb; 42(2):610-7. PubMed ID: 14766824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department.
    Evans H; Balasegaram S; Douthwaite S; Hunter L; Kulasegaram R; Wong T; Querol-Rubiera A; Nebbia G
    PLoS One; 2018; 13(7):e0198520. PubMed ID: 30044779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical performances of simultaneous detection of HIV-1, HIV-2 and hepatitis C- specific antibodies and hepatitis B surface antigen (HBsAg) by multiplex immunochromatographic rapid test with serum samples: A cross-sectional study.
    Robin L; Mboumba Bouassa RS; Nodjikouambaye ZA; Charmant L; Matta M; Simon S; Filali M; Mboup S; Bélec L
    J Virol Methods; 2018 Mar; 253():1-4. PubMed ID: 29208530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity and specificity of commercially available rapid diagnostic tests for viral hepatitis B and C screening in serum samples.
    Jargalsaikhan G; Eichner M; Boldbaatar D; Bat-Ulzii P; Lkhagva-Ochir O; Oidovsambuu O; Dashtseren B; Namjil E; Genden Z; Yagaanbuyant D; Tuya A; Gurjav N; Mordorj A; Bungert A; Dashdorj N; Dashdorj N
    PLoS One; 2020; 15(7):e0235036. PubMed ID: 32667957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent developments in serologic and molecular diagnosis of hepatitis B and C].
    Poljak M; Lepej SZ; Rode OD
    Acta Med Croatica; 2013 Oct; 67(4):281-90. PubMed ID: 24984327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and simple hepatitis assays: encouraging results from a blood donor population in Zimbabwe.
    Mvere D; Constantine NT; Katsawde E; Tobaiwa O; Dambire S; Corcoran P
    Bull World Health Organ; 1996; 74(1):19-24. PubMed ID: 8653812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
    Kuhns MC; Busch MP
    Mol Diagn Ther; 2006; 10(2):77-91. PubMed ID: 16669606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral hepatitis and rapid diagnostic test based screening for HBsAg in HIV-infected patients in rural Tanzania.
    Franzeck FC; Ngwale R; Msongole B; Hamisi M; Abdul O; Henning L; Letang E; Mwaigomole G; Battegay M; Hatz C; Tanner M
    PLoS One; 2013; 8(3):e58468. PubMed ID: 23469281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
    Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.